10
Views
0
CrossRef citations to date
0
Altmetric
Research Article

LITERATURE ALERTS

Pages 253-262 | Published online: 29 Sep 2008

LITERATURE ALERTS

  • A clinical evaluation of a novel liposom al carrier for acyclovir in the topical treatment of recurrent herpes labialis. HCRWITZ, E., PISANTY, S., CZFRNINSKI, R., HEBER, M., ELIAY, E., and TCUITOU, E. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 1999, 87 (6), 700–705.
  • A dose-response study of epidural liposom al bupivacaine in rabbits. MALINWSKY, J. M., LE WIRE, P., MEUNIER, J. F., CHENTANNE, F., PINAUD, M., LENIFITGE, R., and LEGRCS, F. Journal of Controlled Release, 1999, 60 (1), 111–119.
  • A double-blind, randomized, multicentre, crossover study to prove equivalence of pancrea-tin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. HALM, U., USER, C, LCITR, M., KATSCI-TINSKI, M., and MC6SNER, J. Alimentary Pharmacology and Therapeutics, 1999, 13 (7), 951–957.
  • A high sensitivity differential scanning calorimetry study of the interaction between polox-am ers and dim yristoylphosphatidylcholine and dipalmitoylphosphatidylcholine lipo-som e s. CASTILE, J. D., TAYLCR, K. M., and BUCKTON, G. International Journal of Pharmacy, 1999, 182 (1), 101–110.
  • A new efficient method for transfection of neonatal cardiomyocytes using histone H1 in combination with DOSPER liposomal transfection reagent. KO1T, M., HAPERLAND, A., ZAITSEV, S., BUCHBERGER, B., MCRANO I., and BOTTGER, M. Somatic Cell and Molecular Genetics, 1998, 24 (4), 257–261.
  • A new model of retinal pigment epithelium transplantation with microspheres. CGANFSIAN, A., GABRIFLIAN, K., ERNEST, J. T., and PATEL, S. C. Archives of Ophthalmology, 1999, 117, 1192–1200.
  • A new stabilizer used in microencapsulation. LU, Z., BEE, J. Z., and WANG, S. G. Journal of Microencapsulation, 1999, 16 (4), 523–529.
  • A novel method to prepare liposom es containing am ikacin. 21-1ANG, J. H., and ZHU, J. B. Journal of Microencapsulation, 1999, 16 (4), 511–516.
  • A novel vaccine delivery system using immunopotentiating fusogenic liposom es. HAYASHI, A., NAKANESHI, T., KUNESAWA, J., KOND011, M., IMAZU, S., TSUTSUMI, Y., TANAKA, K, MTWARA, H., HAMACKA, T., and MAYUMI, T. Biochemical and Biophysical Research Communications, 1999, 261 (3), 824–828.
  • A simple microcapsule generator design for islet encapsulation. HARDIKAR, A. A., RISBUD, M. V., and BHCNDE R. R Journal of Biosciences, 1999, 24, 371–376.
  • A steady-state fluorescence study of cutinase microencapsulated in AOT reversed micelles at optimal stability conditions. CARYALHCI C. M. L, MELO, E P., 0C6TA, S. M. B., CABRAL, J. M. S., and AIRESBARRC6, M. R. Biotechnology Letters, 1999, 21, 673–681.
  • A topical dosage form of liposom al clofazimine: research and clinical implications. PATEL, V. B., MISRA, A. N., and MARFATIA, Y. S. Die Pharmazie, 1999, 54 (6), 448–451.
  • Ability of the exopolymer excreted by Pseudoalteromonas antarctica NF3, to coat liposom es and to protect these structures against octyl glucoside. DE LA MAZA, A., GODECH, L, LUTZ, 0, PARRA, J. L, SAMS, M., and GUINEA, J. Journal of Biomaterials Science. Polymer Edition, 1999, 10 (5), 557–572.
  • AFM observation of polymer gels incorporated with microspheres. SUZUKI, H., and SUZUKI, A. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 487–493.
  • Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intra-peritoneal transplantation. SIFBERS, U., HCRCITER, A., BRANDHCRST, H., BRANDHCRST, D., HERING B., MERLIN K., BRETZFL, R. G., and ZFKCRN, T. Journal of Molecular Medicine, 1999, 77 (1), 215–218.
  • Antibacterial activity of liposom e-encapsulated antibiotics against Pseudomonas aeruginosa attached to the matrix of human dermis. TRAFNY, E. A., ANTC6 BIELSKA, M., and GRZYBOWSKI, J. Journal of Microencapsulation, 1999, 16 (4), 419–429.
  • Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes. A vehicle-controlled, comparative study in patients with papulopustular acne. FLUHR, J. W., BARSOK GEHRING W., and GLOCR, M. Dermatology, 1999, 198 (3), 273–277.
  • Antibody response in goats vaccinated with liposome-adjuvanted Clostridium perfringens type D epsilon toxoid. UZAL, F. A., WONO J. P., KELLY, W. R., and PRIEST, J. Veterinary Research Communications, 1999, 23 (3), 143–150.
  • Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice. KNIGHT, V., KC6HKINA, N. V., WALDREP, J. C, GIOVANELLA, B. C., and Gilbert, B. E. Cancer Chemotherapy and Pharmacology, 1999, 44 (3), 177–186.
  • Antitumor activity of 13,14-dihydro-15-deoxy-A7)-prostaglandin-A(1)-m ethyl ester integrated into lipid microspheres against hum an ovarian carcinoma cells resistant to cisplatin in vivo. SASAKI, H., MIME, S., AKIYAMA, M., TANAKA, T., HAZATO, A., KURCZUMI, S., FNKUSHIMA, S., and FUKUSHIMA, M. Cancer Research, 1999, 59, 3919–3922.
  • Biodegradable recombinant human erythropoietin loaded microspheres prepared from lin-ear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics. PISTEL, K. F., BITTNER, B., KOLL, H., WINTER, G., and KISSEL, T. Journal of Controlled Release, 1999, 59 (3), 309–325.
  • Bioenergetic effect of liposomal coenzyme Q10 on myocardial ischemia reperfusion injury. NIIBCRI, K, WROBLEWSKI, K R, YOKOYAMA, H., CRESTANELLO, J. A., and WHITMAN, G. J. Biofactors, 1999, 9 (2-4), 307–313.
  • Calcified microspheres as biological entities and their isolation from bone. AARON, J. E., OLIVER, B., CLARKE, N., and CARTER, D. H. Histochemical Journal, 1999, 31, 455–470.
  • Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and char-acterization. CHEN, W., and LU, D. R. Journal of Microencapsulation, 1999, 16, 551–563.
  • Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intra-cellular Leishmania. CHAKRABCRTY, R., DASGUFTA, D., ADHYA, S., and BASU, M. K Biochemical Journal, 1999, 340 ( Pt 2), 393–396.
  • Cationic liposome-mediated DNA transfection in organ otypic explant cultures of the ventral mesencephalon. MURRAY, K D., MCQUILLIN A., STEWART, L, ETHERIDGE, C. J., CODPER, R. G., MILLER, A. D., and GURLINO H. M. Gene Therapy, 1999, 6 (2), 190–197.
  • Cell response to micropatterned surfaces produced with polymeric microspheres. MIYAKI, M., FUJIMOTO K, and KAWAGUCHI, H. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 603–608.
  • Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/I1 study. LOHR, M., BAGO Z. T., BERGMEISTER, H., EDNA, M., FREUND, M., GELBMANN, W., GUNZBURg W. H., JESNOWSKI, R., HAIN J., HAUENSTEIN, K, HENNINGER, W., HOFFMEYER, A., KARLE, P., KRCIER, J. C., KUNDT, G, LIEBE, S., LESERT, U., MULLER, P., PROBST, A., PUSCHEL, K., and RENNER, M. Journal Of Molecular Medicine, 1999, 77 (4), 393–398.
  • Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells. MASTROBATTISTA, E., STCRK G., VAN BLCCtS, L, RESZKA, R., BLOEMEN P. G., CROMMELIN D. J., and HENRICKS, P. A. Biochimica et Biophysica Acta, 1999, 1419 (2), 353–363.
  • Characterization and in-vivo ocular absorption of liposome- encapsulated acyclovir. FRFSTA, M., PANIC°, A. M., Buccul C., GIANNAVOLA, C., and PUGLIST, G The Journal of Pharmacy and Pharmacology, 1999, 51 (5), 565–576.
  • Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion. KITAGUCHI, T., MURATA, M., IIJIMA, K., KAMIDE, K, IMAGAWA, T., and IKEDA, Y. Biochemical and Biophysical Research Communications, 1999, 261 (3), 784–789.
  • Combined systemic and mucosal immunization with microsphere-encapsulated inactivated simian immunodeficiency virus elicits serum, vaginal, and tracheal antibody responses in female rhesus macaques. ISRAEL, Z. R., GETTIE, A., ISHIZAKA, S. T., MISHKIN, E M., STAAS, J., GILLEY, R., MONTEFICRI, D., MARX, P. A., ELDRIDGE, J. H. AIDS Research and Human Retroviruses, 1999, 15, 1121–1136.
  • Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conven-tional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses. xIONq Y. Q, KUPFERWASSER, L I., ZACK, P. M., and BAYER, A. S. Antimicrobial Agents and Chemotherapy, 1999, 43 (7), 1737–1742.
  • Corn parison of antiplatelet activity of microencapsulated aspirin 162.5 mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis [Full text delivery]. BROWN, N, MAY, J. A., WILOCK, R. G., ALLAN, L M., WILSON, A. M., KIFE, P. S., and HEFTINSTALL, S. British Journal of Clinical Pharmacology, 1999, 48, 57–62.
  • Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation. GRIFFITHS, G. D., PHILLIFS, G. J., and BAILEY, S. C. Vaccine, 1999, 17 (20-21), 2562–2568.
  • Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. ADLAKHA HUTCHEON, G., BALLY, M. B., SHEW, C R., and MADDEN, T. D. Nature Biotechnology, 1999, 17 (8), 775–779.
  • Controlled release of aldicarb from lignin loaded ionotropic hydrogel microspheres. KOK, E N., WILKINS, R. M., CAIN, R. B., ARICA, M. Y., ALAEDDINCGLU, G, and HASIRCI, V. Journal of Microencapsulation, 1999, 16, 613–623.
  • Copolymer drug carriers: conjugates, micelles and microspheres. LIEN, C., EISENBERG A., and MAYSINGER, D. ST P Pharma Sciences, 1999, 9, 139–151.
  • Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. FRANSSEN, 0., VANDERVENNET, L, RCDERS, P, and HENNENK, W. E Journal of Controlled Release, 1999, 60, 211–221.
  • Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. BITTNER, B., WITT, C., MADER, K., and KISSEL, T. Journal of Controlled Release, 1999, 60, 297–309.
  • Delivery of liposome-encapsulated HIV type 1 proteins to human dendritic cells for stimula-tion of HIV type 1-specific memory cytotoxic T lymphocyte responses. ZHENG L, HUANG X. L, FAN, 1, BCROWSKI, L, WILSON C. C., and RINALDO C. R. JR. Aids Research and Human Retroviruses, 1999, 15 (11), 1011–1020.
  • Depletion of systemic macrophages by liposome-encapsulated clodronate attenuates increases in brain quinolinic acid during CNS-localized and systemic immune activa-tion. KOENNECKE, L A., mg M. A., PROESCHCLDT, M. G, VAN RODDEN, N., and HEYES, M. P. Journal of Neurochemistry, 1999, 73 (2), 770–779.
  • Design of highly immunogenic liposom al constructs combining structurally independent B cell and T helper cell peptide epitopes. BCRICLER, C., DAUTEL, D., SCHELTE, P., FRISCH, B., WACHSMANN, D., KLEIN, J. P., and SCHUBER, F. European Journal of Immunology, 1999, 29 (7), 2297–2308.
  • Determination of air content in protein microspheres. KVALE, S., DYRSTAD, K. R., SONTUK P. C., and ASBJCRNSEN, 0. A Pharmaceutical Research, 1999, 16, 1316–1319.
  • Deuterium NMR tissue perfusion measurements using the tracer uptake approach: II. Comparison with microspheres in tumors. SIMPSON, N. E., and EVELHOCH, J. L Magnetic Resonance in Medicine, 1999, 42, 240–247.
  • Development of a novel fusogenic viral liposome system (HVJ-liposom es) and its applications to the treatment of acquired diseases. KANEDA, Y. Molecular Membrane Biology, 1999, 16 (1), 119–122.
  • Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. DAUTZENBERG H., Sainur, U., GRASNICIC, G, KARLE, R, MULLER, R, LOHR, M., PELEGRIN, M., PIECHACZYK, M., ROVIBS, K. V., GUNZBURG W. H., SALMONS, B., and SALLER, R. M. Annals of the New York Academy Of Sciences, 1999, 875, 46–63.
  • Development of dried liposom es containing beta-galactosidase for the digestion of lactose in milk. KIM, C. K., CHUNG H. S., LEE, M. K., CHOI, L N, and KIM, M. H. International Journal of Pharmaceutics, 1999, 183 (2), 185–193.
  • Development of the fluorescent microsphere technique for quantifying regional blood flow in small mammals. DEVEC1, D., and EGGINTON, S. Experimental Physiology, 1999, 84, 615–630.
  • Differential effects of free and liposome-associated 1-0-octadecy1-2-0-methylglycerophos-phocholine on protein kinase C. SFIFM, S., OLAH, Z, CUVILLIER, 0., EDSALL, L C., and JANOW, A. S. Febs Letters, 1999, 454 (1-2), 137–141.
  • Difficulties in the assay of liposom al am ikacin (MiKasome)in serum. LOVERING, A. M., WHITE, L 0, and MACGOWAN, A. P. The Journal of Antimicrobial Chemotherapy, 1999, 43 (5), 719–721.
  • Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alky-lated PLA/PLGAs. JCHANSEN R, TAMBER, H., MERKLE, H R, and GANDER, B. European Journal of Pharmaceutics and Biopharmaceutics, 1999, 47 (3), 193–201.
  • Distribution of cam ptothecin after delivery as a liposome aerosol or following intramuscular injection in mice. KC6HKINA, N. V., GILBERT, B. E, WALDREP, J. C., SERYSHEV, A., and KNIGHT, V. Cancer Chemotherapy and Pharmacology, 1999, 44 (3), 187–192.
  • Distribution of daunorubicin and daunorubicinol in human gliom a tumors after adminis-tration of liposom al daunorubicin. ZUCCHETTI, M., BUARDI, A., SILVAM, A., PARISI, I., P1020LROVAZZI, S., and D'INCALCI, M. Cancer Chemotherapy and Pharmacology, 1999, 44 (2), 173–176.
  • Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. BALC1N, K., RIEBESEHL, B. U., and MULLER, B. W. Pharmaceutical Research, 1999, 16 (6), 882–888.
  • Effect of formulation variables on in vitro drug release and micromeritic properties of modified release ibuprofen microspheres. PERUMAL, D., DANGCR, C. M., ALCOCK, R. S., HURBANS, N., and MOOPANAR, K. R. Journal of Microencapsulation, 1999, 16 (4), 475–487.
  • Effect of liposom e-encapsulated clodronate pretreatment on synthetic vector-mediated gene expression in mice. SCHUGHART, K., BISCHOFF, R., HAIM, D. A., BOUSSIF, 0, PERRAUD, F., ACCART, N, RASMUSSEN, U. B., PAYIRAM, A, VAN RCCUEN, N, and KOLBE, H. V. Gene Therapy, 1999, 6 (3), 448–453.
  • Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes. ZOBEL, H. P., WERNER, D., GILBERT, M., NEE, C. R., STIENEKER, E, KREUTER, J., and ZIMMER, A. Journal of Microencapsulation, 1999, 16 (4), 501–509.
  • Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine. ADAMS, L B., SINHA, I., FRANLBLAu, S. G, KRAHENBUHL, J. L, and MEHTA, R. T. Antimicrobial Agents and Chemotherapy, 1999, 43 (7), 1638–1643.
  • Effects of free and liposome-encapsulated hemoglobin on choroidal vascular plexus blood flow, using the rabbit eye as a model system. FLOWER, R., and RUDOLPH, A. S. European Journal of Ophthalmology, 1999, 9 (2), 103–114.
  • Effects of hydrophilic excipients and compression pressure on physical properties and release behavior of aspirin-tableted microcapsules. NCKHODCHI, A., BOLOURTCHIAN, N., and FARID, D. Drug Development and Industrial Pharmacy, 1999, 25 (6), 711–716.
  • Effects of surface perturbations on the quality and the focused-beam excitation of micro-sphere resonance. BART0N, J. P. Journal of the Optical Society of America A: Optics Image Science and Vision, 1999, 16, 1974–1980.
  • Elastase activated liposom al delivery to nucleated cells. PAK, C. C., ERUKULLA, R. K., AHL, P. L, JANOFF, A. S., and MEERS, P. Biochimica et Biophysica Acta, 1999, 1419 (2), 111–126.
  • Elicitins trap and transfer sterols from micelles, liposomes and plant plasma membranes. VAuniRIN, S., MIKES, V., MILAT, M. L, PONCHET, M., MAUME, B., OMAN, H., and BLEIN, J. P. Biochimica et Biophysica Acta, 1999, 1419 (2), 335–342.
  • Embolization with polyhydroxybutyrate (PHB) microspheres: In-vivo studies. KASSAB, A. C, PISKIN, E, Bmac, S., DENKBAs, E B., and XU, K. Journal of Bioactive and Compatible Polymers, 1999, 14, 291–303.
  • Encapsulation and stability of clofazimine liposomes. PATEL, V. B., and MISRA, A. N. Journal of Microencapsulation, 1999, 16 (3), 357–367.
  • Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres. STuREssoN, C., ARTURSSON, P., GHADERI, R., JCHANSEN, K., MIRAZIME, A., UHNCO, I., SVENSSON, L, ALBERTSSON, A. C., and CARLECKS, J. Journal of Controlled Release, 1999, 59 (3), 377–389.
  • Enzymatic degradation of epichlorohydrin crosslinked starch microspheres by alpha-amylase. HAMDI, G., and PONCHEL, G. Pharmaceutical Research, 1999, 16 (6), 867–875.
  • Evaluation of liposom al contrast agents for liver CT in healthy rabbits. PETERsEIN, J., FRANKE, B., FGUILLET, X., and HAMM, B. Investigative Radiology, 1999, 34 (6), 401–409.
  • Evaluation of microspheres containing cytokine neutralizing antibodies in endotoxemia. D'SouzA, M. J., °ETTINGER, C. W., and MILTON, G. V. Drug Development and Industrial Pharmacy, 1999, 25 (6), 727–734.
  • Fabrication, characterization and evaluation of bioceramic hollow microspheres used as microcarriers for 3-D bone tissue formation in rotating bioreactors. QU, Q Q, DUCHEYNE, P., and AYYASWAMY, P. S. Biomaterials, 1999, 20 (11), 989–1001.
  • Factors affecting the degradation rate of poly(lactide-co-glycolide)microspheres in vivo and in vitro. TRACY, M. A, WARD, K. L, FIROUZABADIAN, L, WANG, Y., DONG, N., QIAN, R., and ZHANGs Y. Biomaterials, 1999, 20 (11), 1057–1062.
  • Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. VAN SCIIILEGAARDE, R., and DE VC6, P. Journal of Molecular Medicine, 1999, 77 (1), 199–205. 52 Refs.
  • Flow microsphere immunoassay-based method of virus quantitation. SAMOYLOYA, T. I., and SMITH, B. F. Biotechniques, 1999, 27, 356–361.
  • Fluorescence imaging of single molecules in polymer microspheres. BARNES, M. D., Nq K. C., MCNAMARA, K. R, KUNG C. Y., RAMSEY, J. M., and HILL, S. C. Cytometry, 1999, 36 (3), 169–175.
  • Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection. DE LIMA, M. C., SIMMS, S., FIRES, P., GASPAR, R., SLEPusHKIN, V., and DUZGIJNECS, N. Molecular Membrane Biology, 1999, 16 (1), 103–109.
  • Gene transfer to the rat biliary tract with the HVJ-cationic liposome method. UEHARA, T., HONDA, K, HATANG E, TERAO, R., IimuRo, Y., YAMAMOTO, N, YAMAMOTO, M., KANEDA, Y., and YAMAOKA, Y. Journal of Hepatology, 1999, 30 (5), 836–842.
  • Heparin-immobilized poly(2-hydroxyethylmethacrylate)-based microspheres. DENIZLI, A. Journal of Applied Polymer Science, 1999, 74, 655–662.
  • Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide ther-apy of hepatic malignancies: effects of preparation and neutron activation techniques. NIJSEN, J. F. W., ZCNNENTBERG B. A., WOITTIEZ, J. R. W., ROCK, D. W., SWILDENSYAN WGUDENBERG I. A., YANRIJK, P. P., and SCRIP, A. D. V. European Journal of Nuclear Medicine, 1999, 26, 699–704.
  • Hydrogen peroxide production from reactive liposomes encapsulating enzymes. KASZUBA, M., and JONES, M. N. Biochimica et Biophysica Acta, 1999, 1419 (2), 221–228.
  • Immobilized artificial membrane (IAM)-HPLC for partition studies of neutral and ionized acids and bases in comparison with the liposomal partition system. OFTIGER, C., and WUNDERLI ALLENSPACH, H. Pharmaceutical Research, 1999, 16 (5), 643–650.
  • Importance of the test medium for the release kinetics of a somatostatin analogue from poly(o,t-lactide-co-glycolide)microspheres. BLANCOPRIETO, M. J., BESSEGHIR, K., ORSCLINT, R, HIIMGARTNER, F., DEUSCHFL, C., MFRKLE, H. P., HO, N T., and GANDER, B. International Journal of Pharmaceutics, 1999, 184, 243–250.
  • In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin. TACTILE, S., CAUDRCN, E., LED, E., CCUVREUR, R, ANDRFMONT, A., and FATTAL, E. International Journal of Pharmaceutics, 1999, 183 (1), 73–79.
  • In vivo studies on the role of complement in the clearance of liposomes in rats and guinea pigs. HUONG T. M., HARASHIMA, H., and KIWADA, H. Biological and Pharmaceutical Bulletin, 1999, 22 (5), 515–520.
  • In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline. SANGARE, L, MORISSET, R., and RAVAOARINCRq M. Journal of Medical Microbiology, 1999, 48 (7), 689–693.
  • Incorporation rates, stabilities, cytotoxicities and release of liposomal tetracycline and doxycycline in human serum. SANGARE, L, MCRISSET, It, OMRI, A., and RAVAOARINCRO, M. Journal of Antimicrobial Chemotherapy, 1998, 42 (6), 831–834.
  • Induction of acetylcholinesterase release from erythrocytes in the presence of liposomes. SUZUICI, K., OKUMURA, Y., and SuNAmorq J. Journal of Biochemistry, 1999, 125 (5), 876–882.
  • Induction of mucosal antibody responses by microsphere-encapsulated form alin-inactivated simian immunodeficiency virus in a male urethral challenge model. ISHIZAKA, S. T., ISRAEL, Z. It, GETTIE, A., MISHKIN E M., STAAS, J. K, GILLEY, R. M., DAILEY, P. J., MONTEFICRI, D. C., MARX, P. A., and ELDRIDGE, J. H. Vaccine, 1999, 17, 2817–2825.
  • Induction of mucosal immune responses by administration of liposome- antigen formula-tions and interleukin-12. BACA ESTRADA, M. E, FOLDVART, M., and SNIDER, M. Journal of Interferon and Cytokine Research, 1999, 19 (5), 455–462.
  • Influence of algal exudates and bacteria on growth and survival of white shrimp larvae fed entirely on microencapsulated diets. ALABI, A. 0, OCR, Z. C., JONES, D. A., and LATCHFORD, J. W. Aquaculture International, 1999, 7, 137–158.
  • Influence of formulation parameters on the characteristics of poly(D,t-lactide-co-glycolide) microspheres containing poly(t-lysine)complexed plasmid DNA. CAPAN, Y., WOO, B. H., GEBREKIDAN, S., ARMED, S., and DELUCA, P. P. Journal of Controlled Release, 1999, 60, 279–286.
  • Influence of lipopolymer concentration on liposome degradation and blood clearance. VERmaiREN, C., JCRG11NSEN, K., and FROKJAER, S. International Journal of Pharmaceutics, 1999, 183 (1), 13–16.
  • Influence of the level of ceramides on the permeability of stratum corneum lipid liposomes caused by a C12-betaine/sodium dodecyl sulfate mixture. OCCERA, M., LUPEZ, 0, CODERCH L, PARRA, J. L, and DE LA MAZA, A. International Journal of Pharmaceutics, 1999, 183 (2), 165–173.
  • Interaction between charged soft microcapsules and red blood cells: effects of PEGylation of microcapsule membranes upon their surface properties. MAKIN°, K., UMETSU, M., GOTO, Y., NAKAYAMA, A., SUHARA, T., TSUJIT, J., KIKUCHI, A., OFISHIMA, H., SAKURAI, Y., and OKANO, T. Colloids and Surfaces B: Biointerfaces, 1999, 13, 287–297.
  • Interaction of a lipid-membrane destabilizing enzyme with PEG-liposomes. JCRGENSEN, K., KIFBTER, T., HYLANDFR, I., and VERMEHREN, C. International Journal of Pharmaceutics, 1999, 10, 183 (1), 21–24.
  • Intraarterial instillation of microencapsulated cells in the pancreatic arteries in pig. KROGTR, J. C, BERGMFISTER, H., HCFFMEYFR, A., CELINA, M., KARLE, R, SALLER, R., SCHWENDENWEIN, I., VON RIGMBS, K., LIFIT, S., GUNZBURG W. H., SALMONS, B., HAUENSTF1N, K., LC6ERT, U., and LOHR, M. Annals of the New Y ork Academy of Sciences, 1999, 880, 0077–8923.
  • Intravenous administration of superoxide dismutase entrapped in long circulating lipo-somes. II. In vivo fate in a rat model of adjuvant arthritis. OCRVO M. L, BOFRMAN, 0. C, °YEN, W. J., VAN BLOOTS, L, CRUZ, M. E, CROMMELIN, D. J., and STCRM, G. Biochimica et Biophysica Acta, 1999, 1419 (2), 325–334.
  • Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency. ZUIDAM, N. J., HIRSCH LERNER, D., MARGULIES, S., and BARENHOLZ, Y. Biochimica et Biophysica Acta, 1999, 1419 (2), 207–220.
  • Latexes and microspheres by ring-opening polymerization. Polymerization of cyclic esters. SLOMKOWSKI, S., SC6NOWSKI, S., and GADZINOWSKI, M. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 111–118.
  • Liposomal delivery of heat-shock protein 72 into the heart prevents endotoxin-induced myocardial contractile dysfunction. MELDRUM, D. R., MENG, X., SHAMES, B. D., PamERANrz, B., DONNAHOQ K. K., BANERJEE, A., and HARKEN, A. H. Surgery, 1999, 126 (2), 135–141.
  • Liposom al encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats. ENGELMANN, C., PANTS, Y., BCLARD, J., DIQUET, B., FABRE, M., NAGY, H., SOUBRANE, 0, HOUSSIN, D., and KLATZMANN, D. Human Gene Therapy, 1999, 10 (9), 1545–1551.
  • Liposom al prostaglandin El (TLC C-53)in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group ABRAHAM, E, BAUGHMAN, R., FLETCHER, E, HEARD, S., LAMBERTI, J., LEVY, H., NELSON, L, RUMBAK, M., STEINGRUB, J., TAYLCR, J., PARK, Y. C., HYNDS, J. M., and FREITAq J. Critical Care Medicine, 1999, 27 (8), 1478–1485.
  • Liposome dehydration on nitrocellulose and its application in a biotin immunoassay. MARTCRELL, D., SIEBERT, S. T., and DURST, R. A Analytical Biochemistry, 1999, 271 (2), 177–185.
  • Liposome-encapsulated daunorubicin for PGP-related multidrug resistance. MICHIELI, M., DAMIANI, D., ERMAGCRA, A., MASCLINE, R, MICHELU'ETI, A, MICHELUTTI, T., RUSSO, D., PEA, F., and BACCARAM, M. British Journal of Haematology, 1999, 106 (1), 92–99.
  • Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells. DUZGUNECS, N., FREEZER, E, SIMMS, S., SLEPUSHKIN, V., KONOFKA, K., FLASHER, D., and DE DMA, M. C. Molecular Membrane Biology, 1999, 16 (1), 111–118. 72 Refs.
  • Liposomes as a gene delivery system. ROFERT, C. Brazilian Journal of Medical and Biological Research, 1999, 32 (2), 163–169. 50 Refs.
  • Liposomes as cytokine-supplement in tumor cell-based vaccines. VAN SLCOTEN, M. L, KIRCHEIS, R., KOPPENHAGEN, F. J., WAGNER, E, and STCRM, G. International Journal of Pharmaceutics, 1999, 183 (1), 33–36.
  • Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. CHEN, Q It, KUMAR, D., STASS, S. A., and MIXSCN, A. J. Cancer Research, 1999, 59 (14), 3308–3312.
  • Liposomes: from biophysics to the design of peptide vaccines. FREZARD, F. Brazilian Journal of Medical and Biological Research, 1999, 32 (2), 181–189. 37 Refs.
  • Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres. BARANOV, A., GLAZKOV, R, KISELEV, A., OSTAPENKCI 0, MIKHAILOV, V., IVASCHENKQ T., SABETSKY, V., and BARANOV, V. Gene Therapy, 1999, 6, 1406–1414.
  • Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma-A pilot study. MENEE, R, VENEER, M. C., GAMELIN, E., SAINT ANDRE, J. R, HAYEK, G, JADAUD, E, FOURNEER, D., MERCIER, R, GUY, G., and BENOIT, J. P. Cancer, 1999, 86, 325–330.
  • Low density lipoprotein, and liposome mediated uptake and cytotoxic effect of N4-octadecy1-1-beta-o-arabinofuranosylcytosine in Daudi lymphoma cells. KOLLER LUCAE, S. K., SCHOTT, H., and SCHWENDENER, It A. British Journal of Cancer, 1999, 80 (10), 1542–1549.
  • Magnetic core-shell particles: Preparation of magnetite multilayers on polymer latex micro-spheres. CARUSO, F., SUSHA, A. S., GIERSIq M., and MC:EWALD, H. Advanced Materials, 1999, 11, 950–955.
  • Measurement of microscopic spatial distribution of acoustic radiation force using micro-spheres and electrostatic force. YASUDA, K., Japanese Journal of Applied Physics Part I: Regular Papers, Short Notes & Review Papers, 1999, 38, 3316–3319.
  • Measurements and predictions of the phase velocity and attenuation coefficient in suspen-sions of elastic microspheres. MCBLEY, J., WATERS, K. It, HALL, C. S., MARSH, J. N., HUGHES, M. S., BRANDINBURGER, G. H., and MILLER, J. G. Journal of the Acoustical Society of America, 1999, 106, 652–659.
  • Methyl alpha-o-mannopyranoside-responsive release of microencapsulated glucoamylase. SHIMADA, A., SHINOHARA, K., MCRIGUCHI, K., and NAKAMURA, I. Journal of Bioscience and Bioengineering, 1999, 87, 551–553.
  • Microcapsules of alginate-chitosan. II. A study of capsule stability and permeability. GASEROD, 0., SANNES, A., and SKJAK BRAFK, G. Biomaterials, 1999, 20 (8), 773–783.
  • Microcapsules prepared from alginate and a photosensitive poly(L-lysine). CHANG, S. J., IFF, C H., and WANG Y. J. Journal of Biomaterials Science. Polymer Edition, 1999, 10 (5), 531–542.
  • Microencapsulated NaC1 for oral salt-replacement therapy in infants. CLAVIEZ, A., THIES, R., KLEINEBUDDE, R, and SUTTCRP, M. Journal of the National Cancer Institute, 1999, 91, 1513–1514.
  • Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. ZGOULL1, S., GREK, V., BARRE, G, GOFFINET, G, THONART, R, and ZINNER, S. Journal of Microencapsulation, 1999, 16, 565–571.
  • Microencapsulation of organic solvents in polyelectrolyte multilayer micrometer-sized shells. MOYA, S., SUKHCRUKOy G B., AUCH, M., DONATH, E, and MCHWALD, H. Journal of Colloid and Interface Science, 1999, 216, 297–302.
  • Microencapsulation of paramagnetic particles by pyrroxylin to preserve their responsiveness to oxygen when used as sensors for in vivo EPR oximetry. GALLEZ, B., JERDAN, B. F., and BAUDELET, C. Magnetic Resonance in Medicine, 1999, 42, 193–196.
  • Microencapsulation of rat islets prolongs xenograft survival in diabetic mice. ZHOU, M., CHEN, D., YAO, Q, XIA, Z., WANG, C., and ZHU, H. Chinese Medical Journal, 1998, 111 (5), 394–397.
  • Microencapsulation of the water-soluble pesticide Monocrotophos by an oil in oil interfacial polyaddition method. SHUKLA, P. G., and SIVARAK S. Journal of Microencapsulation, 1999, 16 (4), 517–521.
  • Microspheres of chitosan/poly(vinylalcohol) incorporating tetrasulphonated copper (II) phthalocyanine: preparation and characterization. STOLBERG, J., LARANIEERA, M. C., SANCHEZ, M N., KLUq M., and FAVERE, V. T. Journal of Microencapsulation, 1999, 16 (4), 431–438.
  • Modification of the initial release of a highly water-soluble drug from ethyl cellulose microspheres. LIN, W. J., and WU, T. L Journal of Microencapsulation, 1999, 16, 639–646.
  • Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(DL-lactide). BAIN, D. F., MUNDAY, D. L, and SMITH, A Journal of Microencapsulation, 1999, 16 (3), 369–385.
  • Multicolor fluorescent microspheres as calibration standards for confocal laser scanning microscopy. ZHANGs Y. Z., and CARTER, D. Applied Immunohistochemistry & Molecular Morphology, 1999, 7, 156–163.
  • Negatively therm osensitive release of drug from microcapsules with hydroxypropyl cellu-lose membranes prepared by the Wurster process. ICHIKAWA, H., and FUKUMCRI, Y. Chemical & Pharmaceutical Bulletin, 1999, 47, 1102–1107.
  • New microcapsules based on oligoelectrolyte complexation. BARTKOWIAK, A., and HUNICELER, D. Annals of the New York Academy Of Sciences, 1999, 875, 36–45.
  • Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(oi-lactide-co-glycolide) microspheres. ROTAS, J., PINTO ALPHANDARY, H., LBO, E., PECQUET, S., COUVREUR, P., and FATTAL, E. International Journal of Pharmaceutics, 1999, 183 (1), 67–71.
  • Panniculitis induced by collagen and plexiglas microsphere injections used for aesthetic treatment. BIASI, D., CARAMASCHI, R, CARLETTO, A., GOLOMBARI, R., and BAMBARA, L M. Clinical Rheumatology, 1999, 18, 328–329.
  • Performance of a microsphere plate electron multiplier in APFIM applications. SUBRANDIL S. J., and MILLER, M. K. Ultramicroscopy, 1999, 79, 265–271.
  • Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsules. HCRTELANO, G., XU, N., VANDEM3ERq A., SOLERA, J., CHANG, P. L, and OFC6U, F. A. Human Gene Therapy, 1999, 10 (8), 1281–1288.
  • pH and osmotic pressure inside biodegradable microspheres during erosion. BRUNNER, A., MADER, K., and GCPFERICIL A. Pharmaceutical Research, 1999, 16 (6), 847–853.
  • Phosphorothioate oligonucleotides induction into experimental choroidal neovasculariza-tion by HVJ-liposome system. CGATA, N., °TSUJI, T., MATSUSHIMA, M., KIMOTC/ T., YAMANAKA, R., TAKAHASHI, K, WADA, M., UYAMA, M., and KANEDA, Y. Current Eye Research, 1999, 18 (4), 261–269.
  • Physico-chemical and mass transfer considerations in microencapsulation. GO1EN, M. F. Annals of the New York Academy Of Sciences, 1999, 875, 84–104. 43 Refs.
  • Physico-chemical characterization of liposomes with covalently attached hepatitis A VP3(101-121) synthetic peptide. MUNCV, M., GARCIA, M., REIq F., ALSINA, M. A., and HARD I. Analyst, 1998, 123 (11), 2223–2228.
  • Polarized TH1 responses by liposome-entrapped allergen and its potential in immunotherapy of allergic disorders. SERRA, S., CHUGH, L, and GANGALs S. V. Clinical and Experimental Allergy, 1998, 28 (12), 1530–1537.
  • Poly-m-lactide-co-glycolide microspheres as a controlled release antigen delivery system. LIMA, K. M., and RCORIGUES JNR, J. M. Brazilian Journal of Medical and Biological Research, 1999, 32 (2), 171–180. 63 Refs.
  • Polymeric microcapsules of alachlor and metolachlor: Preparation and evaluation of con-trolled-release properties. DOWLER, C. C., DAILEY, 0. D., and MULLINDC, B. G. Journal of Agricultural and Food Chemistry, 1999, 47, 2908–2913.
  • Polymers for sustained release formulations of dipyridamole-alginate microspheres and tabletted microspheres. GURSOY, A, KARAKUCS, D., and OKAR, I. Journal of Microencapsulation, 1999, 16 (4), 439–452.
  • Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release. MI, F. L, SHYU, S. S., CHEN, C T., and ScHouNq J. Y. Biomaterials, 1999, 20, 1603–1612.
  • Preparation and applications of polymeric microspheres having active ester groups. NAGAI, K., &TASHI, T., KANEKO, It, and TANEGUCHI, T. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 133–136.
  • Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization. KHANG, G., CHO, J. C., TEE, J. W., RHEE, J. M., and TU., H. B. Bio-Medical Materials and Engineering, 1999, 9, 49–59.
  • Preparation and characterization of microencapsulated proteinase inhibitor aprotinin. LARICNOVA, N V., KAZANSKAYA, N. E, LARICNOVA, N I., FONCHEL, G, and DUCHENE, D. Biochemistry-Moscow, 1999, 64, 857–862.
  • Preparation and characterization of polyurea microcapsules with different diamines. HONq
  • K. J., and PARK, S. M. Materials Research Bulletin, 1999, 34, 963–969.
  • Preparation and properties of polymer microspheres dispersed in a silica gel film. ADACHI, M., SUZUKI, Y., KASHIWAGI, N., ISOBE, T., and SENNA, M. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 617–623.
  • Preparation of monodispersed macromolecule microspheres by microwave irradiation and research on the mechanism of its formation LA- Chinese. MAI, M. H., 21-1ANG, W. M., SHEN, E. H., FU, Z., and 21-1ANG4 E Acta Physico-Chemica Sinica, 1999, 15, 747–751.
  • Preparation of phosphorus-containing silica glass microspheres for radiotherapy of cancer by ion implantation. KAWASHITA, M., MIYAII, F., KOKUBO, T., SUZUKI, Y., and KAJIYAMA, K. Journal of Materials Science: Materials in Medicine, 1999, 10, 459–463.
  • Preparation of poly(benzyl methacrylate) microspheres by precipitation polymerization in polymer solution LA- Korean. CHq S. H., KIM K. S., KIM, T. K., and KIM, Y. J. Polymer Korea, 1999, 23, 487–492.
  • Preparation of spray-dried microspheres of indomethacin and examination of the effects of coating on dissolution rates. ERN/WS, D., and YUKSEL, A. Journal of Microencapsulation, 1999, 16 (3), 315–324.
  • Preparation of thermo-sensitive magnetic microspheres and their application to biopro-cesses. KONDO, A., and FUKUDA, H. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 435–438.
  • Preparation of uniform poly(lactide) microspheres by employing the Shirasu Porous Glass (SPG)emulsification technique. MA, G. H., NAGAI, M., and OMI, S. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 383–394.
  • Preventive effect of topical vitamin E-containing liposome instillation on the progression of galactose cataract. Comparison between 5-week and 12-week-old rats fed a 25% galactose diet. OHTA, Y., YAMASAKI, T., NIWA, T., MAJIMA, Y., and ISHIGURC1 I. Experimental Eye Research, 1999, 68 (6), 747–755.
  • Production of microspheres with surface amino groups from blends of poly(lactide-co-glycolide) and poly(epsilon-CBZ-L-lysine) and use for encapsulation. ZHFNG, J., and HCRNSBY, P. J. Biotechnology Progress, 1999, 15, 763–767.
  • Prolongation of the effective duration of cytomedical therapy by re-injecting SK2 hybridom a cells microencapsulated within algin ate -poly(L)lysine -algin ate membranes into human interleukin-6 transgenic mice. MIYAMOTO, H., CICADA, N., YC6HIOKA, T., SUZUKI, It, SAKAMOM K, KATSUME, A., SAITCt H., TSITTSUMI, Y., KUBO, K., NAKAGAWA, S., OFISUG1, Y., and MAYUMI, T. Biological and Pharmaceutical Bulletin, 1999, 22 (3), 295–297.
  • Protective immunity of microsphere-based mucosal vaccines against lethal intranasal challenge with Streptococcus pneumoniae. SEONG, S. Y., CHO, N. H., KWON, I. C., and JMNq S. Y. Infection and Immunity, 1999, 67 (7), 3587–3592.
  • Protein encapsulation in biodegradable amphiphilic microspheres. BCUILLOT, P., UBRICH, N., SOMMER, E, DUC, T. M., LOEFFLER, J. P., and MI ACHERIE, E International Journal of Pharmaceutics, 1999, 181 (2), 159–172.
  • Protein expression in liposom es. OBERHCI,7FR, T., NIERHAUS, K. H., and LUISI, P. L Biochemical and Biophysical Research Communications, 1999, 261 (2), 238–241.
  • Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates. NAM Y. S., and PARK, T. G. Journal of Microencapsulation, 1999, 16, 625–637.
  • Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes. BANDAK, S., RAMU, A., BARENHCI,7, Y., and GABIZON, A. Pharmaceutical Research, 1999, 16 (6), 841–846.
  • Role of macrophages in the localisation of liposom es in lymph nodes after subcutaneous administration. OUSSCREN, C., and STCRM G. International Journal of Pharmaceutics, 1999, 183 (1), 37–41.
  • Separation of liposom es from plasma components using fast protein liquid chromatography. CHOICE, E, AYYOBI, A. F., PRITCHARD, P. H., and MADDEN, T. D. Analytical Biochemistry, 1999, 270 (1), 1–8.
  • Size exclusion properties of polyelectrolyte complex microcapsules prepared from sodium cellulose sulphate and poly[diallyldimethylam m onium chloride]. DAUTZENBERq H., SCHULDT, U., LERCI-IR D., WEEHLECKR H., and EHWALD, R. Journal of Membrane Science, 1999, 162, 165–171.
  • Solubilization of liposomes by sodium dodecyl sulfate: new mechanism based on the direct formation of mixed micelles. LCPEZ, 0., COCERA, M., WEHRLE E, PARRA, J. L, and DE LA MAZA, A. Archives of Biochemistry and Biophysics, 1999, 367 (2), 153–160.
  • Solvent influence on spray-dried biodegradable microspheres. BAIN, D. F., MUNDAY, D. L, and SMITH, A. Journal of Microencapsulation, 1999, 16 (4), 453–474.
  • Stereoselective disposition of ibuprofen enantiomer sustained release microspheres in rats: I. Bioavailability considerations. JANJIKHEL, R. K., and ADEYEYE, C. M. Drug Delivery, 1999, 6, 153–162.
  • Stereoselective disposition of sustained release microspheres of ibuprofen enantiomers in rats: IL Acute gastrointestinal toxicity. JANIIKHEL, R. K., BRICKER, J. D., BCRCCHOVITZ, D., and ADEYEYE, C. M. D rug D eliv ery, 1999, 6, 163–170.
  • Studies on smaller (similar to 315 lam) microcapsules: IV. Feasibility and safety of intrahe-patic implantations of small alginate poly-L-lysine microcapsules. LEBLOND, F. A., SIMARD, G., HENLEY, N., ROCHELFAU, B., HUET, P. M., and HALLE, J. P. Cell Transplantation, 1999, 8, 327–337.
  • Surface properties of m on odisperse poly(acrylamide-co-acrylic acid) hydrogel microspheres prepared by a membrane emulsification technique. NAGASHIMA, S., KOIDE, M., ANDO S., MAKING, K., TSUKAMOTO, T., and OFISHIMA, H. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 221–227.
  • Surfactant-induced leakage from liposomes: a comparison among different lecithin vesicles. MEMOLI, A., ANNESIM, M. C., and PETRALITO S. International Journal of Pharmaceutics, 1999, 184 (2), 227–235.
  • Sustained release chitosan microspheres prepared by novel spray drying methods. HE, P., DAVIS, S. S., and ILLUM L Journal of Microencapsulation, 1999, 16 (3), 343–355.
  • Synergistic effect of microencapsulation and immunoalteration on islet allograft survival in bioartificial pancreas. ZFKCRN, T. D., HCRCHER, A., SIEBERS, U., FEDERLIN, K., and BRETZEL, R. G. Journal of Molecular Medicine, 1999, 77 (1), 193–198.
  • Synthesis of monodisperse polymeric microspheres including polyimide prepolymer by using SPG emulsification technique. OM, S., MATSUDA, A., IMAMURA, K., NAGAI, M., and MA, G. H. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 373–381.
  • Systemic mycoses during prophylactical use of liposom al am photericin B (Am bisom e) after liver transplantation. LCRF, T., BRAUN F., RUCITEL, R., MULLER, A., SATTLER, B., and RINGE, B. Mycoses, 1999, 42 (1-2), 47–53.
  • Targeting of therapeutics to the liver: liposomes and viral vectors. DI' CAMPLI, C., WU, J., and 2ERN, M. A. Alcoholism, Clinical and Experimental Research, 1999, 23 (5), 950–954. 36 Refs.
  • Temperature-dependent interaction of thermo-sensitive polymer-modified liposomes with (Ni cells. KONG, K., NAKAI, R., MCRIMOTO, K., and TAKAGISHI, T. FEBS Letters, 1999, 456 (2), 306–310.
  • The effectiveness of gamma-irradiated products on microspheres of polylactide-co-glycolide containing bupivacaine. MONTANARI, L, CIRANNE SIGNCRETTI, E, vALvo, L, FATTETENE, P., CONTI, B., GENTA, I., and CILURZO, F. Bollettino Chimico Farmaceutico, 1999, 138 (3), 91–98.
  • The influence of liposome-encapsulated prostaglandin El on hydrogen peroxide concentra-tions in the exhaled breath of patients with the acute respiratory distress syndrome. HEARD, S. 0., IJONGTINE, K, TOTH, I., PUYANA, J. C., PCITENZA, B., and SMYRNICS, N Anesthesia and Analgesia, 1999, 89 (2), 353–357.
  • The production of uniformly sized polymer microspheres. AMSDEN, B. Pharmaceutical Research, 1999, 16, 1140–1143.
  • The relationship of interaction forces in the protein adsorption onto polymeric microspheres. YCON, J. Y., KIM J. H., and KIM W. S. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 413–419.
  • The rescue effect of 15-deoxyspergualin on intraperitoneal microencapsulated xenoislets. HSU, B. R. S., CHANO F. H., JUANO J. H., HUANG, Y. Y., and FU, S. H. Cell Transplantation, 1999, 8, 307–315.
  • The use of aqueous PEG/dextran phase separation for the preparation of dextran micro-spheres. STENEKES, R. J., FRANSSEN, 0., VAN BQVIMEL, E M., CROMMELIN, D. J., and HENNINK, W. E. International Journal of Pharmaceutics, 1999, 183 (1), 29–32.
  • Toxicology of intrahepatic arterial administration of interventional phosphorus-32 glass microspheres to domestic pigs. LIU, L, TENO G. J., 21-IANG, D. S., SONG, J. Z., HE, S. C., GUO, J. H., and FANG W. Chinese Medical Journal, 1999, 112, 632–636.
  • Transcranial Doppler pattern after intracarotid papaverine and prostaglandin El incorpo-rated in lipid microsphere in patients with vasospasm. KANAMARU, K., WAGA, S., KUGA, Y., NAKAMURA, E, and KAMATA, N. Neurologia Medico-Chirurgica, 1998, 38 Suppl, 152–155.
  • Transderm al ion toph ore tic delivery of en oxacin from various liposome-encapsulated formulations. FANG J. Y., SUNG K. C., UN, H. H., and FANG, C. L Journal of Controlled Release, 1999, 60 (1), 1–10.
  • Transferrin as a targeting ligand for liposomes and anticancer drugs. SINGH, M. Current Pharmaceutical Designs, 1999, 5 (6), 443–451. 51 Refs.
  • Transplantation of islets using microencapsulation: studies in diabetic rodents and dogs. LANZA, R. R, ECKER, D. M., KUHTREEBER, W. M., MARSH, J. R, RINGELING, J., and CHICK, W. L Journal of Molecular Medicine, 1999, 77 (1), 206–210.
  • Transplantation of pancreatic islets contained in minimal volume microcapsules in diabetic high mammalians. CALAFICRE, R., BASTA, G., LUCA, G, BC6ELLI, C., BUFALARI, A., BUFALARI, A, CASSARAM, M. R, GIUSTCVZI, G M., and BRUNETTI, P. Annals of the New York Academy of Sciences, 1999, 875, 219–232. 17 Refs.
  • Two-photon fluorescence spectrum in an atom plus dielectric microsphere system. KLIMOV, V. V., and LETOICHOV, V. S. JET P Letters, 1999, 70, 189–195.
  • Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres. BITTNER, B., and KISSEL, T. Journal of Microencapsulation, 1999, 16 (3), 325–341.
  • Unusual electrostatic effects on binding of Clq to anionic liposomes: role of anionic phospholipid domains and their line tension. BRADLEY, A J., MAURER SFUREJ, E., BROOKS, D. E., and DEVINE, D. V. Biochemistry, 1999, 38 (25), 8112–8123.
  • Upconversion lasing of a thulium-ion-doped fluorozirconate glass microsphere. FUJIWARA, H., and SASAKI, K. Journal of Applied Physics, 1999, 86, 2385–2388.
  • Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines. OCRDCBES, M. D., MCRETTI, J. L, DE BECO, V., BENAZZOUZ, F., and STARZEC, A. Nuclear Medicine Communications, 1999, 20 (5), 433–437.
  • Use of cefazolin microspheres to treat localized m ethicillin- resistant Staphylococcus aureus infections in rats [Full text delivery]. FALLON, M. T., SHAFER, W., and JACOB, E Journal of Surgical Research, 1999, 86, 97–102.
  • Use of microencapsulated fish oil as a means of increasing n-3 polyunsaturated fatty acid intake. HIGGINS, S., CARRCLL, Y. L, °BRIEN N. M., and MCRRISSEY, P. A. Journal of Human Nutrition and Dietetics, 1999, 12, 265–271.
  • UV curable polyurethane-based microspheres. HIRCEE, M., ZHOU, J. H.,, and KADOWAKI, F. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1999, 153, 481–485.
  • Visceral leishmaniasis in renal transplant recipients: successful treatment with liposom al am ph ote ricin B (Am Bisome). BCLETIS, J. N., PEFANES, A., STATHAKIS, C., FRICKE H., KCETAKIS, A., and GIAMARELLOU, H. Clinical Infectious Diseases, 1999, 28 (6), 1308–1309.
  • Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? DE VCS, R, VAN STRAATEN, J. E, NIEUWENHUIZEN, A. G., DE GRCOT, M., PLOEG, R. J., DE HAAN, B. J., and VAN SCHILMAARDE, R. Diabetes, 1999, 48 (7), 1381–1388.
  • Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biode-gradable microspheres? PFAN J. M., BOURY, F., VEMERJULIHNNE, M. C., MENU, R, PROUST, J. E., and BENOIT, J. P. Pharmaceutical Research, 1999, 16, 1294–1299.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.